← FDA Drug Approvals (Drugs@FDA)
TYVASO DPI
NDA · New Drug Application · Sponsor: UNITED THERAP · Approved 2022-05-23
Drug application
- FDA Application #
NDA214324- Application type
- New Drug Application
- Brand name
- TYVASO DPI
- Generic name
- TREPROSTINIL
- Active ingredients
- TREPROSTINIL
- Dosage form
- POWDER
- Route
- INHALATION
- Marketing status
- Prescription
- Sponsor
- UNITED THERAP
- Manufacturer
- United Therapeutics Corporation
- First approval
- 2022-05-23
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown